$3250 | Single User
$4650 | Site License
$5650 | Global License

Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jun 2020 | 270611 | In Stock
Related Topics: Abbott , Agencies , Cell Culture , Roche

Introduction

REPORT HIGHLIGHT

Influenza diagnostics market was valued at USD 2.83 billion by 2019, growing with 6.1% CAGR during the forecast period, 2020-2026

Market Dynamics

The growing prevalence of chronic diseases such as blood disorder, heart disorders, and diabetes and the increasing geriatric population all across the globe are the major factors boosting the growth of the global influenza diagnostics market. In addition, the emergence of advancements in technology for diagnostic tests and increasing government initiatives for countering influenza are other factors impelling market growth.

The immunosuppresses individuals, especially those suffering from chronic diseases, are more susceptible to influenza and thus, the demand for influenza diagnostic products is been increasing. The data presented by Centers for Disease Control and Prevention (CDC), approximately 85 laboratory-confirmed paediatric deaths were witnessed in Puerto Rico, District of Columbia, and 33 other states. In 2016, the mortality due to influenza in the U.S. was 4,605, which indicated 1.4 deaths per 100,000 individuals. However, the mutation of the virus serotype is predicted to hinder the market growth during the forecast period.

Test Type Takeaway

The rapid influenza diagnostic tests (RIDT) segment accounted for the largest market share in 2019 and is expected to grow at a healthy growth rate during the forecast period. This is mainly because these test types are frequently used for the diagnosis of influenza. Moreover, RIDT is considered as the gold standard test working for the diagnosis of influenza and delivers quick results, which is further estimated to dominate the global market by 2030. On the other hand, the cell culture test type is commonly considered as a reference method and is extensively used when the incidence rate of the disease is being tested. This test type provides accurate statistics along with an ability to precisely distinguish between the several types of influenza viruses. Thus, the cell culture segment is estimated to grow at an impressive growth rate during the period of forecast.

End Use Takeaway

The hospitals end-use segment for overall influenza diagnostics registered for the majority of market share in 2019 and is projected to steadily slow down owing to the advent of POCT laboratories as these laboratories deliver accurate results. Thus, the POCT end use segment is anticipated to grow at the fastest growth rate by 2030 owing to its ease of use and advantage that it can be used by anyone without any requirement for expertise. In addition, with the advent POCT of advanced technology, the reliance of the physicians and the public on these tests has increased significantly.

Regional Takeaway

Presently, the North America region is leading the overall influenza diagnostics market attributing to a strong focus of the CDC on regulating the disease rates. Additionally, the high technological advancements in this region coupled with the rising healthcare spending are projected to propel the regional market growth by 2030. On the other hand, the Asia Pacific market for influenza diagnostics is projected to witness the fastest growth owing to factors such as significant disease burden and high population density in the region.

Key players of the market include:

• Quidel Corporation

• Alere, Inc.

• Roche Diagnostics

• Siemens Healthineers

• Abbott Laboratories

• Dickinson and Company

• Becton

• Thermo Fisher Scientific

• Bio-Rad Laboratories, Inc.

The market size and forecast for each segment and sub-segments has been considered as below:

• Historical Year – 2015 to 2018

• Base Year – 2019

• Estimated Year – 2020

• Projected Year – 2026

TARGET AUDIENCE

 Traders, Distributors, and Suppliers

 Manufacturers

 Government and Regional Agencies

 Research Organizations

 Consultants

 Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE

 Rapid Influenza Diagnostic Tests (RIDT)

 Reverse Transcription Polymerase Chain Reaction (RT-PCR)

 Cell Culture

 Others

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USE

 Hospitals

 Point of Care Testing (POCT)

 Clinical Laboratories

 Others

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY REGION

 North America

o The U.S.

o Canada

 Europe

o Germany

o France

o Italy

o Spain

o United Kingdom

o Rest of Europe

 Asia Pacific

o India

o China

o South Korea

o Japan

o Singapore

o Rest of APAC

 Latin America

o Brazil

o Mexico

o Argentina

o Rest of LATAM

 Middle East and Africa

o Saudi Arabia

o United Arab Emirates

o Rest of MEA

Table of Contents
for Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

  • TABLE OF CONTENT

    1. INFLUENZA DIAGNOSTICS MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Market Snippet

    2.1.1. Market Snippet by Test Type

    2.1.2. Market Snippet by End Use

    2.1.3. Market Snippet by Region

    2.2. Competitive Insights

    3. INFLUENZA DIAGNOSTICS KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. INFLUENZA DIAGNOSTICS INDUSTRY STUDY

    4.1. Porter’s Five Forces Analysis

    4.2. Marketing Strategy Analysis

    4.3. Pipeline Analysis (Potential Phase III Candidates)

    4.4. Growth Prospect Mapping

    4.5. Regulatory Framework Analysis

    4.6. COVID-19 Impact Analysis

    4.6.1. Pre-COVID-19 Impact Analysis

    4.6.2. Post-COVID-19 Impact Analysis

    5. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    5.3. Breakdown Data, by Key manufacturer

    5.3.1. Established Player Analysis

    5.3.2. Emerging Player Analysis

    6. INFLUENZA DIAGNOSTICS MARKET – BY TEST TYPE

    6.1. Overview

    6.1.1. Segment Share Analysis, By Test Type, 2019 & 2026 (%)

    6.2. Rapid Influenza Diagnostic Tests (RIDT)

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.4. Cell Culture

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.5. Others

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7. INFLUENZA DIAGNOSTICS MARKET – BY END USE

    7.1. Overview

    7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)

    7.2. Hospitals

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.3. Point of Care Testing (POCT)

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.4. Clinical Laboratories

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.5. Others

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8. INFLUENZA DIAGNOSTICS MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)

    8.2. North America

    8.2.1. Overview

    8.2.2. Key Manufacturers in North America

    8.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.2.4. North America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)

    8.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    8.2.6. U.S.

    8.2.6.1. Overview

    8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.2.7. Canada

    8.2.7.1. Overview

    8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Key Manufacturers in Europe

    8.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.3.4. Europe Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)

    8.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    8.3.6. Germany

    8.3.6.1. Overview

    8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.7. Italy

    8.3.7.1. Overview

    8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.8. United Kingdom

    8.3.8.1. Overview

    8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.9. France

    8.3.9.1. Overview

    8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.10. Rest of Europe

    8.3.10.1. Overview

    8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Key Manufacturers in Asia Pacific

    8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)

    8.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    8.4.6. India

    8.4.6.1. Overview

    8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.7. China

    8.4.7.1. Overview

    8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.8. Japan

    8.4.8.1. Overview

    8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.9. South Korea

    8.4.9.1. Overview

    8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.10. Rest of APAC

    8.4.10.1. Overview

    8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5. Latin America

    8.5.1. Overview

    8.5.2. Key Manufacturers in Latin America

    8.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.5.4. Latin America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)

    8.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    8.5.6. Brazil

    8.5.6.1. Overview

    8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.7. Mexico

    8.5.7.1. Overview

    8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.8. Argentina

    8.5.8.1. Overview

    8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.9. Rest of LATAM

    8.5.9.1. Overview

    8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.6. Middle East and Africa

    8.6.1. Overview

    8.6.2. Key Manufacturers in Middle East and Africa

    8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)

    8.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    8.6.6. Saudi Arabia

    8.6.6.1. Overview

    8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.6.7. United Arab Emirates

    8.6.7.1. Overview

    8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Quidel Corporation

    9.1.1. Company Snapshot

    9.1.2. Financial Performance

    9.1.3. Product Benchmarking

    9.1.4. Strategic Initiatives

    9.2. Alere, Inc.

    9.3. Roche Diagnostics

    9.4. Siemens Healthineers

    9.5. Abbott Laboratories

    9.6. Dickinson and Company

    9.7. Becton

    9.8. Thermo Fisher Scientific

    9.9. Bio-Rad Laboratories, Inc.

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. References

    11.3. Abbreviations

    11.4. Disclaimer

    11.5. Contact Us

List Of Tables
in Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Influenza Diagnostics market: Test Type Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Test Type

TABLE Global Influenza Diagnostics market, by Test Type 2015-2026 (USD Million)

TABLE Influenza Diagnostics market: End Use Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by End Use

TABLE Global Influenza Diagnostics market, by End Use 2015-2026 (USD Million)

TABLE Influenza Diagnostics market: Regional snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Influenza Diagnostics market, by Region 2015-2026 (USD Million)

TABLE North America Influenza Diagnostics market, by Country, 2015-2026 (USD Million)

TABLE North America Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)

TABLE North America Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Europe Influenza Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Europe Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)

TABLE Europe Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Asia Pacific Influenza Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Asia Pacific Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)

TABLE Asia Pacific Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Latin America Influenza Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Latin America Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)

TABLE Latin America Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Middle East and Africa Influenza Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Middle East and Africa Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)

TABLE Middle East and Africa Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

List Of Figures, Charts and Diagrams
in Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Figures

FIGURE Influenza Diagnostics market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparision Study

FIGURE Competitive Landscape; Key company market share analysis, 2018

FIGURE Test Type segment market share analysis, 2019 & 2026

FIGURE Test Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rapid Influenza Diagnostic Tests (RIDT) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Reverse Transcription Polymerase Chain Reaction (RT-PCR) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Cell Culture segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE End Use segment market share analysis, 2019 & 2026

FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Hospitals segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Point of Care Testing (POCT) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Clinical Laboratories segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2026

FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE North America Influenza Diagnostics market share and leading players, 2018

FIGURE Europe Influenza Diagnostics market share and leading players, 2018

FIGURE Asia Pacific Influenza Diagnostics market share and leading players, 2018

FIGURE Latin America Influenza Diagnostics market share and leading players, 2018

FIGURE Middle East and Africa Influenza Diagnostics market share and leading players, 2018

FIGURE North America Influenza Diagnostics market share analysis by country, 2018

FIGURE U.S. Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Canada Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Europe Influenza Diagnostics market share analysis by country, 2018

FIGURE Germany Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Spain Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Italy Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE UK Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE France Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of the Europe Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Asia Pacific Influenza Diagnostics market share analysis by country, 2018

FIGURE India Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE China Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Japan Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE South Korea Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Singapore Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of APAC Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Influenza Diagnostics market share analysis by country, 2018

FIGURE Brazil Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Mexico Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Argentina Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of LATAM Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Influenza Diagnostics market share analysis by country, 2018

FIGURE Saudi Arabia Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE United Arab Emirates Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270611 | AV91

Number of Pages

169

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Influenza Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Influenza B Infections Global Clinical Trials Review, H1, 2016
Influenza B Infections Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial rep...
20 Jan 2016 by Global Data USD $2,500 More Info
Pandemic Influenza Global Clinical Trials Review, H1, 2016
Pandemic Influenza Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report,...
20 Jan 2016 by Global Data USD $2,500 More Info
Influenza A Infections Global Clinical Trials Review, H1, 2016
Influenza A Infections Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial rep...
20 Jan 2016 by Global Data USD $2,500 More Info
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical...
20 Jan 2016 by Global Data USD $2,500 More Info
Swine Influenza Global Clinical Trials Review, H1, 2016
Swine Influenza Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “S...
20 Jan 2016 by Global Data USD $2,500 More Info
Seasonal Influenza Global Clinical Trials Review, H2, 2015
Seasonal Influenza Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report,...
30 Dec 2015 by Global Data USD $2,500 More Info
Influenza A Infections Global Clinical Trials Review, H2, 2015
Influenza A Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial rep...
30 Dec 2015 by Global Data USD $2,500 More Info
Pandemic Influenza Global Clinical Trials Review, H2, 2015
Pandemic Influenza Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report,...
30 Dec 2015 by Global Data USD $2,500 More Info
Influenza B Infections Global Clinical Trials Review, H2, 2015
Influenza B Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial rep...
30 Dec 2015 by Global Data USD $2,500 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...